The Tapestri Platform provides an unprecedented level of quantification of DNA integrations in significantly less time compared to other techniques such as qPCR and does so at single-cell resolution. These characteristics allow for the rapid optimization of transduction protocols or homology-directed repair (HDR) protocols during therapy development and streamlined testing and release of transduced or integrated cells during the manufacturing of therapeutic products. A version written in English is also available here.